BLLN

BillionToOne, Inc.

• TipRanks·2d ago

  BillionToOne, Inc. Class A (BLLN) Receives a Buy from BTIG

• TipRanks·3d ago

  J.P. Morgan Sticks to Their Buy Rating for BillionToOne, Inc. Class A (BLLN)

• PUBT·4d ago

  BillionToOne SVP Sales Nancy JoAnn Johnson disposes of 14,199 common shares worth $1.82 million

• TipRanks·5d ago

  BillionToOne appoints Ethan Dmitrovsky as Chief Medical Officer

• PUBT·5d ago

  BillionToOne appoints Ethan Dmitrovsky as chief medical officer, oncology

• Reuters·5d ago

  BILLIONTOONE APPOINTS ETHAN DMITROVSKY, MD, AS CHIEF MEDICAL OFFICER, ONCOLOGY, TO LEAD MEDICAL STRATEGY FOR NORTHSTAR

• PUBT·07/15 20:38

  BillionToOne CTO David Tsao reports disposal of 22,000 common shares worth $2.75 million

• PUBT·07/13 20:39

  BillionToOne Chief Product Officer Sakakibara Shan Riku disposes of 8,000 common shares for $1 million

• NASDAQ·07/09 11:56

  Billiontoone Reaches Analyst Target Price

• PUBT·07/08 23:07

  BillionToOne Chairman and CEO Oguzhan Atay disposes of 25,000 common shares worth $3.05 million

• PUBT·07/07 00:38

  BillionToOne SVP Sales and Commercial Operations Nancy JoAnn Johnson sells 801 shares for $100,036.87

• PUBT·07/01 20:24

  BillionToOne SVP of Laboratory Operations John Roderick ten Bosch disposes of 1,416 common shares for $169,920

• Seeking Alpha·07/01 16:32

  BTIG’s top small and mid-cap stocks for H2, ranked by SA Quant

• TipRanks·06/29 20:33

  BillionToOne Expands Oncology Lab Capacity with New Lease

• PUBT·06/29 16:40

  BillionToOne study finds Northstar Response ctDNA test outperforms imaging in predicting immunotherapy outcomes